A comparative study of the genetic diversity of the 42 kDa fragment of the merozoite surface protein 1 in Plasmodium falciparum and P. vivax

Infection, Genetics and Evolution

Volumn 7, Issue 2, 2007, Pages 180-187

  Pacheco, M Andreina ^a   Poe, Amanda C ^b   Collins, William E ^b   Lal, Altaf A ^b   Tanabe, Kazuyuki ^c   Kariuki, Simon K ^d   Udhayakumar, Venkatachalam ^b   Escalante, Ananias A ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

Genetic diversity; Malaria; Merozoite; MSP 1; MSP 1 19 kDa; Plasmodium; Vaccine

Indexed keywords

MEROZOITE SURFACE PROTEIN 2;

ARTICLE; CELL INVASION; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHROCYTE; GENETIC VARIABILITY; HOST PARASITE INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN DEGRADATION; SPECIES DIFFERENCE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; HOST-PARASITE RELATIONS; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHYLOGENY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SELECTION (GENETICS); SEQUENCE ALIGNMENT; VARIATION (GENETICS);

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIMATES;

EID: 33846569926     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2006.08.002     Document Type: Article

References (51)

1. Ahlborg N., Ling I.T., Howard W., Holder A.A., and Riley E.M. Protective immune responses to the 42-hilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by large adjacent 33-kDa region. Infect. Immun. 70 (2002) 820-825
2. Chang S.P., Kramer K.J., Yamaga K.M., Kato A., Case S.E., and Siddiqui W.A. Plasmodium falciparum: Gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolate. Exp. Parasitol. 67 (1988) 1-11
3. Chitnis C.E., and Miller L.H. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med. 180 (1994) 497-506
4. Coatney G.R., Collins W.E., Warren M., and Contacos P.G. The Primate Malarias (1971), U.S. Government Printing Office
5. Conway D.J., Cavanagh D.R., Tanabe K., Roper C., Mikes Z.S., Sakihama N., Bojang K.A., Oduola A.M., Kremsner P.G., Arnot D.E., Greenwood B.M., and McBride J.S. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat. Med. 6 (2000) 689-692
6. Drakeley C.J., Corran P.H., Coleman P.G., Tongren J.E., McDonald S.L., Carneiro I., Malima R., Lusingu J., Manjurano A., Nkya W.M., Lemnge M.M., Cox J., Reyburn H., and Riley E.M. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 5108-5113
7. Escalante A.A., Lal A.A., and Ayala F.J. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Genetics 149 (1998) 189-202
8. Escalante A.A., Cornejo O.E., Rojas A., Udhayakumar V., and Lal A.A. Assessing natural selection in malarial parasites. Trends. Parasitol. 20 (2004) 388-395
9. Escalante A.A., Cornejo O.E., Freeland D.E., Poe A.C., Durrego E., Collins W.E., and Lal A.A. A monkey's tale: The origin of Plasmodium vivax as a human malaria parasite. Proc. Nat. Acad. Sci. U.S.A. 102 (2005) 1980-1985
10. Espinosa A.M., Sierra A.Y., Barrero C.A., Cepeda L.A., Cantor E.M., Lombo T.B., Guzman F., Avila S.J., and Patarroyo M.A. Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments. Vaccine 21 (2003) 1033-1043
11. Fu Y.X., and Li W.H. Statistical tests of neutrality of mutations. Genetics 133 (1993) 693-709
12. Galinski M.R., Medina C.C., Ingravallo P., and Barnwell J.W. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell 69 (1992) 1213-1226
13. Good M.F., Stanisic D., Xu H., Elliott S., and Wykes M. The immunological challenge to developing a vaccine to the blood stages of malaria parasites. Immunol. Rev. 201 (2004) 254-267
14. Hammer M.F., Blackmer F., Garrigan D., Nachman M.W., and Wilder J.A. Human population structure and its effects on sampling Y chromosome sequence variation. Genetics 164 (2003) 1495-1509
15. Han H.J., Park S.G., Kim S.H., Hwang S.Y., Han J., Traicoff J., Kho W.G., and Chung J.Y. Epidermal growth factor-like motifs 1 and 2 of Plasmodium vivax merozoite surface protein 1 are critical domains in erythrocyte invasion. Biochem. Biophys. Res. Commun. 320 (2004) 563-570
16. Holder A.A., and Freeman R.R. Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody. J. Exp. Med. 156 (1982) 1528-1538
17. Hudson R.R., and Kaplan N.L. Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics 111 (1985) 147-164
18. Hughes A.L. Positive selection and intrallelic recombination at the merozoite surface antigen-1 (MSA-1) locus of Plasmodium falciparum. Mol. Biol. Evol. 9 (1992) 381-393
19. Hughes M.K., and Hughes A.L. Natural selection on Plasmodium surface proteins. Mol. Biochem. Parasitol. 71 (1995) 99-113
20. 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa. J. Immunol. 173 (2004) 666-672
21. Jongwutiwes S., Tanabe K., Nakazawa S., Yanagi T., and Kanbara H. Sequence variation in the tripeptide repeats and T cell epitopes in P190 (MSA-1) of Plasmodium falciparum from field isolates. Mol. Biochem. Parasitol. 51 (1992) 81-89
22. Jongwutiwes S., Tanabe K., and Kanbara H. Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP-1) of Plasmodium falciparum from field isolates. Mol. Biochem. Parasitol. 59 (1993) 95-100
23. Joy D.A., Feng X., Mu J., Furuya T., Chotivanich K., Krettli A.U., Ho M., Wang A., White N.J., Suh E., Beerli P., and Su X.Z. Early origin and recent expansion of Plasmodium falciparum. Science 300 (2003) 318-321
24. Kaneko O., Kimura M., Kawamoto F., Ferreira M.U., and Tanabe K. Plasmodium falciparum: allelic variation in the merozoite surface protein 1 gene in wild isolates from southern Vietnam. Exp. Parasitol. 86 (1997) 45-57
25. Kumar S., Tamura K., Jakobsen I.B., and Nei M. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17 (2001) 1244-1245
26. Kumar S.V., Ranjan S., Saxena V., Rajesh V., Roy S.K., Kochar D., Ranjan A., and Das A. Plasmodium falciparum: Genetic diversity of C-terminal region of MSP-1 in isolates from Indian sub-continent. Exp. Parasitol. 110 (2005) 384-388
27. Li W.H. Unbiased estimation of the rates of synonymous and nonsynonymous substitution. J. Mol. Evol. 36 (1993) 96-99
28. McDonald J.H., and Kreitman M. Adaptive protein evolution at the Adh locus in Drosophila. Nature 351 (1991) 652-654
29. Miller L.H., Roberts T., Shahabuddin M., and McCutchan T. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol. 59 (1993) 1-14
30. Nei M., and Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3 (1986) 418-426
31. Nei M., and Kumar S. Molecular Evolution and Phylogenetics (2000), Oxford University Press
32. 19 across distantly related Plasmodium species. Nat. Med. 6 (2000) 91-95
33. Okech B.A., Corran P.H., Todd J., Joynson-Hicks A., Uthaipibull C., Egwang T.G., Holder A.A., and Riley E.M. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect. Immun. 72 (2004) 1557-1567
34. Polley S.D., Weedall G.D., Thomas A.W., Golightly L.M., and Conway D.J. Orthologous gene sequences of merozoite surface protein 1 (MSP1) from Plasmodium reichenowi and P. gallinaceum confirm an ancient divergence of P. falciparum alleles. Mol. Biochem. Parasitol. 142 (2005) 25-31
35. Putaporntip C., Jongwutiwes S., Seethamchai S., Kanbara H., and Tanabe K. Intragenic recombination in the 3′ portion of the merozoite surface protein 1 gene of Plasmodium vivax. Mol. Biochem. Parasitol. 109 (2000) 111-119
36. Putaporntip C., Jongwutiwes S., Sakihama N., Ferreira M.U., Kho W.G., Kaneko A., Kanbara H., Hattori T., and Tanabe K. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 16348-16353
37. Putaporntip C., Jongwutiwes S., Iwasaki T., Kanbara H., and Hughes A.L. Ancient common ancestry of the merozoite surface protein 1 of Plasmodium vivax as inferred from its homologue in Plasmodium knowlesi. Mol. Biochem. Parasitol. 146 (2006) 105-108
38. Qari S.H., Shi Y.P., Goldman I.F., Nahlen B.L., Tibayrenc M., and Lal A.A. Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen. Mol. Biochem. Parasitol. 92 (1998) 241-252
39. Rodríguez L.E., Urquiza M., Ocampo M., Curtidor H., Suarez J., Garcia J., Vera R., Puentes A., Lopez R., Pinto M., Rivera Z., and Patarroyo M.E. Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes. Vaccine 20 (2002) 1331-1339
40. Rozas J., Sanchez-DelBarrio J.C., Messeguer X., and Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19 (2003) 2496-2497
41. Sachdeva S., Ahmad G., Malhotra P., Mukherjee P., and Chauhan V.S. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli. Infect. Immun. 72 (2004) 5775-5782
42. Saitou N., and Nei M. The Neighbor-Joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4 (1987) 406-425
43. Shi Y.P., Sayed U., Qari S.H., Roberts J.M., Udhayakumar V., Oloo A.J., Hawley W.A., Kaslow D.C., Nahlen B.L., and Lal A.A. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect. Immun. 64 (1996) 2716-2723
44. Snounou G., and White N.J. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol. 20 (2004) 333-339
45. Stanisic D.I., Martin L.B., Gatton M.L., and Good M.F. Inhibition of 19-kDa C-terminal region of merozoite surface protein-1-specific antibody responses in neonatal pups by maternally derived 19-kDa C-terminal region of merozoite surface protein-1-specific antibodies but not whole parasite-specific antibodies. J. Immunol. 172 (2004) 5570-5581
46. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123 (1989) 585-595
47. Takala S.L., Escalante A.A., Branch O.H., Kariuki S., Biswas S., Chaiyaroj S.C., and Lal A.A. Genetic diversity in the Block 2 region of the merozoite surface protein 1 (MSP-1) of Plasmodium falciparum: additional complexity and selection and convergence in fragment size polymorphism. Infect. Genet. Evol. 6 (2006) 417-424
48. Tanabe K., Mackay M., Goman M., and Scaife J.G. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 195 (1987) 273-287
49. Tanabe K., Sakihama N., and Kaneko A. Stable SNPs in malaria antigen genes in isolated populations. Science 303 (2004) 493
50. Udhayakumar V., Anyona D., Kariuki S., Shi Y.P., Bloland P.B., Branch O.H., Weiss W., Nahlen B.L., Kaslow D.C., and Lal A.A. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. J. Immunol. 154 (1995) 6022-6030
51. Yang C., Collins W.E., Sullivan J.S., Kaslow D.C., Xiao L., and Lal A.A. Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant. Infect. Immun. 67 (1999) 342-349